There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

The exposure-response model is a nonlinear, mixed-effects Emax model that included repeated measurements of RPF for each subject in the study (>200 data points), resulting in a modeled E max (maximum ...

The CLEAR-IE registry data, which show clinical efficacy, are just the first step—an RCT may be forthcoming, researchers say.